Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s RTOR Program Produces Approvals About One Month Sooner Than Priority Review Goal
Aug 05 2022
•
By
Bridget Silverman
• Source: Nielsen Hobbs; the Pink Sheet | Shutterstock, Getty images
More from US FDA Performance Tracker
More from Regulatory Trackers